Home › Funds › Morgan Stanley › MXCT
Morgan Stanley position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)3.69M sh
Reported value held$4.54M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.29M | $15.80M | New |
| Q4 2021 | 1.38M | $14.02M | Add |
| Q1 2022 | 1.30M | $9.10M | Reduce |
| Q2 2022 | 1.55M | $7.35M | Add |
| Q3 2022 | 1.49M | $9.68M | Reduce |
| Q4 2022 | 1.56M | $8.52M | Add |
| Q1 2023 | 1.68M | $8.32M | Add |
| Q2 2023 | 1.62M | $7.45M | Reduce |
| Q3 2023 | 1.33M | $4.13M | Reduce |
| Q4 2023 | 3.48M | $16.36M | Add |
| Q1 2024 | 3.52M | $14.75M | Add |
| Q2 2024 | 4.64M | $18.19M | Add |
| Q3 2024 | 4.82M | $18.74M | Add |
| Q4 2024 | 4.41M | $18.34M | Reduce |
| Q1 2025 | 7.00M | $19.11M | Add |
| Q1 2025 | 7.00M | $19.11M | Add |
| Q2 2025 | 7.03M | $15.32M | Hold |
| Q2 2025 | 7.03M | $15.32M | Hold |
| Q3 2025 | 6.70M | $10.58M | Reduce |
| Q4 2025 | 4.43M | $6.87M | Reduce |
| Q1 2026 | 3.69M | $2.59M | Reduce |
| Q2 2026 | 3.69M | $4.54M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026
- UBS Group AG 284.27K sh · $349.65K · Q2 2026